🔎 Trials Near Me

Home › Lymphoma › District of Columbia

Pag-aaral pangklinika para sa Lymphoma sa District of Columbia

7 pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa mga site sa District of Columbia.

Mga Lungsod sa District of Columbia

Opisyal na teksto ng pag-aaral (English)

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Children's National Medical Center, Washington D.C.
Nagre-recruitPhase 1/2
12 Months – 21 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04870944

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  • Georgetown University, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06084936

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Medstar Georgetown University Hospital, Washington D.C.
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

  • Georgetown University (Data Collection Only), Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT05389293

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • MedStar Georgetown University Hospital, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

Mosaic Trial for Stem Cell Transplant Recipients

  • Georgetown University School of Medicine, Washington D.C.
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06960993

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

  • George Washington University, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT05663502

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.